AbCellera Biologics

$9.42 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Subscribe

About AbCellera Biologics

AbCellera Biologics Inc. is a biotechnology company, which offers drug discovery platform that searches and analyzes natural immune systems to find antibodies that can be used to prevent and treat disease. Its platform incorporates and integrates technology tools from engineering, microfluidics, single-cell analysis, high-throughput genomics, machine learning and data science. The Company is engaged in the business of applying a multiple technology in its medical research and development to extract antibody-based drugs. Its solution allows to source, search, decode, engineer and deliver lead antibodies. The Company's solution allows to source, search, decode, engineer and deliver lead antibodies. The Company's subsidiaries include AbCellera Properties Inc., AbCellera Properties Columbia Inc., AbCellera US Holdings Inc., Channel Biologics Pty Ltd., Lineage Biosciences Inc. and Trianni, Inc.

Stock Analysis

last close $9.71
1-mo return -35.2%
3-mo return -36.5%
avg daily vol. 2M
52-week high 55.22
52-week low 9.6
market cap. $2.8B
forward pe 70.4
annual div. -
roe 43.8%
ltg forecast 10%
dividend yield -
annual rev. $444M
inst own. 43.7%
baraka

Subscribe now for daily local and international financial news

Subscribe